The APOE gene, particularly the APOE4 allele, is the strongest genetic risk factor for sporadic AD (Zhao et al., 2020) and serves as a significant biomarker for disease susceptibility (Farrer et al., 1997), making it an important target for gene therapy in AD. Here, APOE is linked to Alzheimer disease.